- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Programmed death-ligand 1 (CD274), commonly known as PD-L1, is a cell surface immune checkpoint protein that regulates T cell activation through interaction with PD-1 and contributes to immune evasion in cancer. PD-L1 Biotinylated Antibody / CD274 Detection Antibody is designed for sensitive detection of PD-L1 expression in applications where signal amplification and flexible detection strategies are required. Its use in biotin-streptavidin systems enables enhanced signal intensity and adaptable assay design across multiple experimental formats.
PD-L1 antibody, also referred to as CD274 antibody or B7-H1 antibody, enables detection of PD-L1 across tumor cells and immune cell populations including macrophages, dendritic cells, and activated lymphocytes. The biotinylated format allows indirect detection through streptavidin-conjugated reporters, supporting increased sensitivity compared to directly labeled antibodies. This is particularly advantageous in tissue-based assays and low-abundance target detection, where signal amplification improves visualization of PD-L1 expression.
Biotin-streptavidin detection systems provide substantial versatility, allowing the same primary antibody to be paired with different enzymatic or fluorescent reporters depending on experimental requirements. This flexibility supports optimization of detection conditions, adjustment of signal intensity, and compatibility with diverse assay platforms including immunohistochemistry and multiplex detection workflows. The amplified signal generated through this system enhances contrast between positive and negative populations, facilitating clearer interpretation of staining patterns.
Within tissue environments, PD-L1 expression is often heterogeneous and can be localized to tumor cells as well as tumor-associated immune infiltrates. Amplified detection using a biotinylated antibody supports visualization of both strong and low-level expression across these compartments, enabling more comprehensive assessment of immune checkpoint distribution and tumor-immune interactions.
This clone is supported by protein microarray specificity validation using a HuProt(TM) platform containing more than 19,000 full-length human proteins. Clone PDL1/2746 demonstrates highly selective binding to PD-L1 with strong signal dominance and minimal cross-reactivity. This high specificity is especially important in amplified detection systems, where non-specific binding could otherwise be enhanced alongside true signal.
PD-L1 is a type I transmembrane protein belonging to the B7 family and is primarily localized to the cell surface, with additional intracellular pools reflecting protein synthesis and turnover. Its expression is dynamically regulated by inflammatory cytokines such as interferon-gamma, contributing to variable expression patterns across tissues and experimental conditions.
Overall, PD-L1 Biotinylated Antibody enables sensitive, amplified detection of CD274 expression with flexible assay compatibility and high specificity. Its performance supports detailed analysis of immune checkpoint expression, tumor microenvironment interactions, and low-abundance PD-L1 detection in research applications.
This PD-L1 antibody is part of a broader PD-L1 antibody panel offered by NSJ Bioreagents.
Optimal dilution of the PD-L1 Biotinylated Antibody / CD274 Detection Antibody should be determined by the researcher.
A portion of amino acids 39-191 from the human protein was used as the immunogen for the PD-L1 antibody.
Store the PD-L1 antibody at 2-8oC (up to one month) or aliquot and store at -20oC (longer term).
CD274 antibody, PD-L1 antibody, B7-H1 antibody, Programmed death-ligand 1 antibody, PDCD1 ligand antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.